(Q39889492)

15 September 2017

title

DC therapy induces long-term NK reactivity to tumors via host DC. (English)

1 reference

15 September 2017

Kanako Shimizu

1

1 reference

15 September 2017

Shin-ichiro Fujii

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

European Journal of Immunology

15 September 2017

published in

1 reference

15 September 2017

volume

39

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

457-468

1 reference

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

A contribution of mouse dendritic cell-derived IL-2 for NK cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Effector and regulatory events during natural killer-dendritic cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Self-tolerance, dendritic cell (DC)-mediated activation and tissue distribution of natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Dendritic cell-induced activation of adaptive and innate antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Unpulsed dendritic cells induce broadly applicable anti-tumor immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Recognition of bacterial glycosphingolipids by natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Invariant NKT cells amplify the innate immune response to lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Regulatory T cells in immune surveillance and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Activation of Invariant NKT Cells by Toll-like Receptor 9-Stimulated Dendritic Cells Requires Type I Interferon and Charged Glycosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

Functional interactions between dendritic cells and NK cells during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

inferred from DOI database lookup

7 January 2021

based on heuristic

Type I IFN contributes to NK cell homeostasis, activation, and antitumor function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838794

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJI.200838794

1 reference

15 September 2017

1 reference